Cencora Balance Sheet
NYSE: CORHealth CareOther PharmaceuticalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cencora financial position
At the end of fiscal 2025, Cencora reported total assets of $76.59 billion, up 14.1% from a year earlier against total liabilities of $74.84 billion. Shareholders' equity stood at $1.51 billion, or 2.0% of assets. The company held $4.36 billion in cash and equivalents against $7.66 billion of debt, a net debt position of $3.30 billion.
The current ratio (current assets divided by current liabilities) was 0.90, meaning short-term obligations exceed short-term assets. Debt-to-equity was 5.08.
Summary generated from market data by MetaCap's automated system. Methodology
Cencora balance sheet (annual)
| Fiscal year (USD) | FY 20252025-09-30 | FY 20242024-09-30 | FY 20232023-09-30 | FY 20222022-09-30 | FY 20212021-09-30 | FY 20202020-09-30 | FY 20192019-09-30 | FY 20182018-09-30 | FY 20172017-09-30 | FY 20162016-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.36B | 3.13B | 2.59B | 3.39B | 2.55B | 4.60B | 3.37B | 2.49B | 2.44B | 2.74B |
| Receivables | 25.23B | 23.87B | 20.91B | 18.45B | 18.17B | 13.85B | 12.39B | 11.31B | 10.30B | 9.18B |
| Inventory | 20.49B | 19.00B | 17.45B | 15.56B | 15.37B | 12.59B | 11.06B | 11.92B | 11.46B | 10.72B |
| Total Current Assets | 52.24B | 47.72B | 42.80B | 39.59B | 38.80B | 33.06B | 28.13B | 25.89B | 24.30B | 22.85B |
| Property, Plant & Equipment | 2.54B | 2.18B | 2.14B | 2.14B | 2.16B | 1.48B | 1.77B | 1.89B | 1.80B | 1.53B |
| Goodwill | 13.68B | 9.32B | 9.57B | 8.50B | 9.03B | 6.71B | 6.71B | 6.66B | 6.04B | 5.99B |
| Intangible Assets | 3.77B | 4.00B | 4.43B | 4.33B | 5.26B | 1.89B | 2.29B | 2.95B | 2.83B | 2.97B |
| Total Assets | 76.59B | 67.10B | 62.56B | 56.56B | 57.34B | 44.27B | 39.17B | 37.67B | 35.32B | 33.64B |
| Accounts Payable | 54.72B | 50.94B | 45.84B | 40.19B | 38.01B | 31.71B | 28.39B | 26.84B | 25.40B | 23.93B |
| Short-Term Debt | 117.78M | 576.33M | 641.34M | 1.07B | 300.21M | 501.26M | 139.01M | 151.66M | 12.12M | 610.21M |
| Total Current Liabilities | 57.82B | 54.28B | 48.83B | 43.48B | 41.36B | 33.85B | 29.58B | 27.87B | 26.82B | 25.28B |
| Long-Term Debt | 7.54B | 3.81B | 4.15B | 4.63B | 6.38B | 3.62B | 4.03B | 4.16B | 3.43B | 3.58B |
| Total Liabilities | 74.84B | 66.31B | 61.89B | 56.49B | 56.75B | 45.11B | 36.18B | 34.62B | 33.25B | 31.51B |
| Shareholders' Equity | 1.51B | 645.94M | 522.00M | -211.56M | 223.35M | -1.02B | 2.88B | 2.93B | 2.06B | 2.13B |
| Retained Earnings | 6.53B | 5.42B | 4.32B | 2.98B | 1.67B | 518.34M | 4.24B | 3.72B | 2.40B | 2.30B |
| Total Debt | 7.66B | 4.39B | 4.79B | 5.70B | 6.68B | 4.12B | 4.17B | 4.31B | 3.44B | 4.19B |
| Net Cash (Debt) | -3.30B | -1.26B | -2.20B | -2.31B | -4.14B | 478.23M | -798.70M | -1.82B | -1.01B | -1.44B |
| Shares Outstanding | 193.94M | 194.94M | 200.81M | 206.20M | 208.09M | 204.23M | 206.76M | 213.22M | 217.99M | 220.05M |
This table shows 10 annual periods of Cencora's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow COR's reporting calendar. What is a balance sheet?